Evaluation of LIH383 as a new neuro-pharmacological modulator

Project Details


Pain-relaying receptors represent valuable targets for the pharmaceutical industry but classical drug therapies often lead to tolerance, dependence and depression. We recently identified a new pain-related receptor and, in parallel developed, a modulator of this receptor with unique properties. These two findings promise a valuable alternative for the treatment of chronic pain and depressive disorders with possibly reduced side effects.
Effective start/end date1/03/1914/11/19


  • FNR - Fonds National de la Recherche: €30,000.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.